FMR LLC - BELLICUM PHARMACEUTICALS INC ownership

BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 83 filers reported holding BELLICUM PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 2.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
FMR LLC ownership history of BELLICUM PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$2,549,000
+14.0%
756,358
-1.2%
0.00%
Q4 2018$2,235,000
-69.4%
765,358
-35.6%
0.00%
-100.0%
Q3 2018$7,315,000
-46.5%
1,187,578
-35.9%
0.00%
-50.0%
Q2 2018$13,664,000
+4.4%
1,851,555
-7.2%
0.00%0.0%
Q1 2018$13,085,000
-40.8%
1,994,672
-24.1%
0.00%
-33.3%
Q4 2017$22,114,000
-29.9%
2,629,542
-3.7%
0.00%
-25.0%
Q3 2017$31,547,000
-3.2%
2,731,342
-2.1%
0.00%0.0%
Q2 2017$32,589,000
-7.6%
2,790,142
-2.4%
0.00%0.0%
Q1 2017$35,276,000
-24.6%
2,858,677
-16.8%
0.00%
-33.3%
Q4 2016$46,784,000
-31.8%
3,434,964
-0.3%
0.01%
-33.3%
Q3 2016$68,548,000
+121.0%
3,444,606
+43.9%
0.01%
+125.0%
Q2 2016$31,020,000
+168.6%
2,393,544
+93.8%
0.00%
+100.0%
Q1 2016$11,547,000
-70.0%
1,235,000
-34.9%
0.00%
-60.0%
Q4 2015$38,441,000
+164.6%
1,896,454
+89.6%
0.01%
+150.0%
Q3 2015$14,530,000
-31.7%
1,000,0000.0%0.00%
-33.3%
Q2 2015$21,270,0001,000,0000.00%
Other shareholders
BELLICUM PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Virtus ETF Advisers LLC 15,086$306,0000.84%
Baker Brothers Advisors 4,865,647$98,627,0000.82%
Cormorant Asset Management, LP 300,000$6,081,0000.73%
SPHERA FUNDS MANAGEMENT LTD. 231,515$4,693,0000.69%
QVT Financial LP 340,986$6,912,0000.39%
Graticule Asia Macro Advisors LLC 87,000$1,763,0000.29%
Hatteras Investment Partners, LP 10,410$211,0000.28%
MCDANIEL TERRY & CO 33,836$686,0000.18%
Highlander Capital Management, LLC 6,500$132,0000.12%
EverPoint Asset Management, LLC 265,000$5,372,0000.11%
View complete list of BELLICUM PHARMACEUTICALS INC shareholders